Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/88126
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer |
Author: | Smit, E. Burgers, S. Biesma, B. Smit, H. Eppinga, P. Dingemans, A. Joerger, M. Schellens, J. Vincent, A. van Zandwijk, N. Groen, H. |
Citation: | Journal of Clinical Oncology, 2009; 27(12):2038-2045 |
Publisher: | American Society of Clinical Oncology |
Issue Date: | 2009 |
ISSN: | 0732-183X 1527-7755 |
Statement of Responsibility: | Egbert F. Smit, Sjaak A. Burgers, Bonne Biesma, Hans J.M. Smit, Pier Eppinga, Anne-Marie C. Dingemans, Markus Joerger, Jan H. Schellens, Andrew Vincent, Nico van Zandwijk, and Harry J.M. Groen |
Abstract: | Abstract not available |
Keywords: | Humans Adenocarcinoma Carcinoma, Large Cell Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Lung Neoplasms Disease Progression Carboplatin Guanine gamma-Glutamyl Hydrolase Methylenetetrahydrofolate Reductase (NADPH2) Thymidylate Synthase Glutamates Membrane Transport Proteins Antineoplastic Combined Chemotherapy Protocols Neoplasm Staging Prognosis Treatment Outcome Survival Rate Risk Factors Follow-Up Studies Pharmacogenetics Polymorphism, Genetic Adult Aged Aged, 80 and over Middle Aged Female Male Reduced Folate Carrier Protein Pemetrexed |
Rights: | © 2009 by American Society of Clinical Oncology |
DOI: | 10.1200/JCO.2008.19.1650 |
Published version: | http://dx.doi.org/10.1200/jco.2008.19.1650 |
Appears in Collections: | Aurora harvest 7 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.